Tag archive for ‘Robert A. Bradway’
Amgen acquisition of Five Prime Therapeutics
By businessnewstoday On Thursday, March 4th, 2021
0 Comments

Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab

(adsbygoogle = window.adsbygoogle || []).push({}); Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 More...

By pharmanewsdaily On Tuesday, November 5th, 2019
0 Comments

Amgen to take 20.5% stake in Chinese biotech company BeiGene for $2.7bn

US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company BeiGene for about $2.7 billion, as per the latest pharma acquisition news. The Beijing-based BeiGene is More...